Literature DB >> 2969464

'Subcortical dementia': the neuropsychological evidence.

R G Brown1, C D Marsden.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 2969464     DOI： 10.1016/0306-4522(88)90246-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN： 0306-4522            Impact factor:   3.590


× No keyword cloud information.
  37 in total

1.  Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life.

Authors:  L Angelini; N Nardocci; V Rumi; C Zorzi; L Strada; M Savoiardo
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

2.  Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

Authors:  I Litvan; E Mohr; J Williams; C Gomez; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 3.  Neurology.

Authors:  A N Gale; J M Gibbs; A H Schapira; P K Thomas
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

4.  Enhanced frontal function in Parkinson's disease.

Authors:  R Cools; A Miyakawa; M Sheridan; M D'Esposito
Journal:  Brain       Date:  2009-12-07       Impact factor: 13.501

5.  Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.

Authors:  P Soliveri; M B Zappacosta; L Austoni; P Caffarra; A Scaglioni; D Testa; E Palazzini; T Caraceni; F Girotti
Journal:  Ital J Neurol Sci       Date:  1994-11

6.  Visual association test to detect early dementia of the Alzheimer type.

Authors:  J Lindeboom; B Schmand; L Tulner; G Walstra; C Jonker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

7.  Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.

Authors:  Raffaele Nardone; Igor Florio; Piergiorgio Lochner; Frediano Tezzon
Journal:  Exp Brain Res       Date:  2005-03-08       Impact factor: 1.972

8.  Dopaminergic modulation of the planning phase of skill acquisition in Parkinson's disease.

Authors:  Brenda Hanna-Pladdy; Kenneth M Heilman
Journal:  Neurocase       Date:  2009-12-08       Impact factor: 0.881

9.  Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.

Authors:  M Asahina; T Suhara; H Shinotoh; O Inoue; K Suzuki; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

10.  Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.

Authors:  T W Robbins; M James; A M Owen; K W Lange; A J Lees; P N Leigh; C D Marsden; N P Quinn; B A Summers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.